Inhibitory effect of polyphloretin phosphate upon platelet aggregation and hemodynamic and respiratory changes caused by thrombin and protamine.
D000818:Animals; D001011:Aorta / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects*; D007263:Infusions, Parenteral; D008970:Molecular Weight; D010693:Phloretin / Q000008:administration & dosage / Q000494:pharmacology*; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011479:Protamines / Q000037:antagonists & inhibitors*; D011651:Pulmonary Artery / Q000187:drug effects; D011652:Pulmonary Circulation / Q000187:drug effects; D012119:Respiration / Q000187:drug effects*; D013917:Thrombin / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D013997:Time Factors
D011479:Protamines; D013917:Thrombin; D010693:Phloretin